Early lupus patient data sends Kezar Life Sciences' stock soaring after-hours

Early lupus patient data sends Kezar Life Sciences' stock soaring after-hours
·2 min read

The company's stock also took a substantial dive early last month after the same drug missed its mark in two other diseases.